Merriman Wealth Management, LLC Sangamo Therapeutics, Inc Transaction History

Merriman Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$6.21 - $11.83 $161,460 - $307,580	-26,000 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$5.05 - $8.85 $25,250 - $44,250	5,000 Added 23.81%	26,000 $166,000
Q4 2019 Jan 23, 2020	SELL	$8.03 - $11.7 $8,029 - $11,700	-1,000 Reduced 4.55%	21,000 $176,000
Q3 2019 Oct 18, 2019	BUY	$9.05 - $12.22 $63,350 - $85,540	7,000 Added 46.67%	22,000 $199,000
Q2 2019 Jul 31, 2019	BUY	$8.75 - $13.03 $43,750 - $65,150	5,000 Added 50.0%	15,000 $1.59 Million
Q4 2018 Jan 28, 2019	BUY	$9.51 - $16.6 $95,100 - $166,000	10,000 New	10,000 $119,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $160M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Merriman Wealth Management, LLC with notifications on news.